CLARITY News and Research

RSS

The lipid-exchanged, anatomically rigid, imaging/immunostaining compatible, tissue hydrogel (CLARITY) method was initially designed in 2013 by Chung and Deisseroth at the Stanford University School of Medicine. Using this process, post-mortem organs can be labeled for proteins and nucleic acids, enabling analysis of intact samples to create detailed 3D images.

FDA issues Complete Response Letter for AcelRx's Zalviso NDA

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Company's new drug application (NDA) for Zalviso (sufentanil sublingual tablet system).

26 Jul 2014

Resarchers offer insight into how low-wage jobs affect public health, economy in Syracuse, N.Y.

As low-wage jobs continue to show strong gains since the recession, findings from the Low-Wage Workers' Health Project led by Upstate Medical University is offering insight into how these jobs affect public health and the economy in Syracuse, N.Y., and reflect national trends in issues related to low-wage workers.

14 Jul 2014

Allianz Worldwide Care receives Best International Private Health Insurance Provider award

Global health insurer, Allianz Worldwide Care, has won Best International Private Health Insurance Provider at the Professional Adviser International Fund & Product Awards 2014. Now in their 15th year, the Awards were established to honour cutting-edge financial services groups that offer products and services across international borders.

3 Jul 2014

Drug therapy for ADHD does not entail increased risk of suicide attempts

A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the British Medical Journal (BMJ).

19 Jun 2014

Clot-busting medications for treating pulmonary embolism patients linked with fewer deaths

Bringing clarity to a decades-long debate, a national team of researchers led by experts from the Perelman School of Medicine at the University of Pennsylvania has found that adding clot-busting medications known as thrombolytics to conventional approaches when treating sudden-onset pulmonary embolism patients is associated with 47 percent fewer deaths than using standard intravenous or under-the-skin anticoagulant medications alone.

18 Jun 2014

National study provides insights into current approaches and barriers for patient-centered care

In order to meet new cancer program accreditation standards, institutions have placed new focus on patient navigation, psychosocial distress screening, and survivorship care plans.

9 Jun 2014

Telemedicine in action: an interview with Ian Jackson, Managing Director, Imerja

Telemedicine is a term used to describe the use of information technology in delivering curative or clinical care healthcare, allowing medical specialists to communicate with patients and other medical staff, regardless of their physical location.

21 May 2014

GSA announce winners of GSA Poster Awards at 55th Annual Drosophila Research Conference

The Genetics Society of America (GSA) and the Drosophila research community are pleased to announce the winners of GSA Poster Awards at the 55th Annual Drosophila Research Conference, which took place in San Diego, March 26-30, 2014.

21 May 2014

BioLineRx announces financial results for Q1 2014, provides operational update

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.

20 May 2014

Retrophin reports net loss of $70.6 million for first quarter 2014

Retrophin, Inc. today reported its financial results for the quarter ended March 31, 2014.

14 May 2014

Phasefocus invited to present a two day workshop on label-free cell imaging at CATIM

Phase Focus Ltd (Phasefocus), the company that is revolutionising microscopy and imaging with the Phasefocus Virtual Lens®, has been invited to present a two day workshop on label-free cell imaging at CATIM – the Centre for Alternative Testing and In-vitro Monitoring on Tuesday 24th and Wednesday 25th June. The meeting will take place at the Frenchay Campus of the University of the West of England, Bristol.

From Phase Focus Limited 6 May 2014

Armetheon reaches agreement with FDA on SPA for final pivotal trial of tecarfarin

Armetheon, Inc., today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the final pivotal trial of tecarfarin.

29 Apr 2014

Waist circumference, body mass index, and postmenopausal breast cancer incidence

A study of predominantly white women finds a larger waist circumference is associated with higher risk of postmenopausal breast cancer, but not beyond its contribution to BMI. The study, by American Cancer Society researchers, fails to confirm previous findings that body shape itself is an independent risk factor for breast cancer. The current study appears in the April 2014 issue of Cancer Causes, and Control.

16 Apr 2014

Cartoons could help educate, empower patients to cope better with chronic conditions

Researchers from the University of Southampton have shown that cartoons could be a beneficial way of educating patients and empowering them to cope better with their long term conditions.

29 Mar 2014

Royal Philips to present innovative imaging and informatics solutions at ACC 2014

Royal Philips today announced its participation in the American College of Cardiology Conference Annual Meeting in Washington, D.C., where it will present the innovative imaging and informatics solutions that are helping clinicians deliver timely diagnoses and minimally-invasive treatments to a growing cardiovascular patient population.

From Philips Healthcare 28 Mar 2014

Toxicologists reveal new methods for estimating infants' exposure to POPs

Toxicologists are revealing new methods and models for estimating infants' exposure to persistent organic pollutants (POPs) today at the Society of Toxicology (SOT) 53rd Annual Meeting and ToxExpo in Phoenix, Ariz.

26 Mar 2014

Singulex signs agreement to co-develop the Sgx Clarity system with Tecan

Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMC) technology for clinical diagnostics and scientific discovery, today announced an agreement to co-develop the Sgx Clarity system with Tecan, a leading global provider of laboratory automation instruments.

From Tecan 25 Mar 2014

Yongye’s revenue increases 49.4% to $661.9M in fourth quarter 2013

Yongye International, Inc.("Yongye" or the "Company"), a leading developer, manufacturer, and distributor of crop nutrient products in the People's Republic of China ("PRC"), today announced its financial results for the fourth quarter and full year ended December 31, 2013.

17 Mar 2014

Findings reinforce need for standardization of living liver donor liver evaluation consent forms

New research reveals that 57% of liver transplant centers use living donor evaluation consent forms that include all the elements required by the Centers for Medicare and Medicaid Services (CMS) and 78% of centers addressed two-third or more of the items recommended by the Organ Procurement and Transplant Network (OPTN).

14 Mar 2014

Skip health coverage and the penalty may exceed expectations

The notion that, during its first year, the penalty for not getting health insurance is relatively small is not entirely accurate. News outlets also report on how the health law is affecting retiree health care, insurers' rate-setting processes, pregnant women's coverage and provider networks.

13 Mar 2014